Investor News Links


Reports and
Conference Summaries:


This occasional collection is designed to help biotechnology (aka biotech) investors with their research.

Moderna Therapeutics and mRNA by Elie Dolgin, Nature Volume 522, Issue 7554, June 3, 2015. This is about the problems in creating mRNA therapies, including IP issues. Moderna is not publicly traded at this time.

To Partner or Not to Partner, That is the Question by Michael Becker @ Seeking Alpha, March 10, 2011